Future Healthcare of America
Net BuyingFUTU·US·🇺🇸 US
100%buys·0%sells
11 transactions$42KTotal buys·7 buys
$0Total sells·0 sells
33 insiders
Last: Jun 27, 2019
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 9, 24 | XU LI | Proposed sale | $12.0M | |
| Sep 18, 23 | Zhang Jie | Proposed sale | $9.0M | |
| Jun 27, 19 | NL Life Sciences BV | Exercise | - | |
| Jun 27, 19 | NL Life Sciences BV | Exercise | - | |
| Nov 13, 18 | SPENCER CHRISTOPHER J | Grant | $101K | |
| Nov 13, 18 | Busshaus John Lawrence | Grant | $101K | |
| Nov 11, 14 | Busshaus John Lawrence | Buy | $2K | |
| Aug 29, 14 | SPENCER CHRISTOPHER J | Buy | $3K | |
| Aug 29, 14 | SPENCER CHRISTOPHER J | Buy | $10K | |
| Aug 29, 14 | SPENCER CHRISTOPHER J | Buy | $6K |
Busshaus John Lawrence (CFO) recently executed a buy of $2K in Future Healthcare of America shares on November 11, 2014. Overall insider sentiment is bullish (100% purchases).
Future Healthcare of America (FUTU) has recorded 11 insider operations, including 7 open-market purchases ($42K), 0 sales ($0) and 4 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (100% purchases).
Recent activity is concentrated over 1 months in the last year.
Among the most active insiders are SPENCER CHRISTOPHER J (CEO), Busshaus John Lawrence (CFO) & NL Life Sciences BV (MAJOR SHAREHOLDER), with respectively 59, 40, 2 transactions.
Across all 13 recorded transactions, the breakdown by type is: buys (7, 54%), grant (2, 15%), exercise (2, 15%), proposed_sale (2, 15%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Future Healthcare of America has recorded 11 insider operations in total, including 7 open-market purchases ($42K), 0 sales ($0) and 4 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on June 27, 2019.
Insiders at Future Healthcare of America are currently net buyers, with 100% purchases and 0% sales across all reported transactions. Total buy volume is $42K versus $0 in sales, indicating a bullish insider sentiment.
InsiderLens tracks 3 insiders at Future Healthcare of America (FUTU). SPENCER CHRISTOPHER J (CEO, 59 tx), Busshaus John Lawrence (CFO, 40 tx), NL Life Sciences BV (MAJOR SHAREHOLDER, 2 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for FUTU is bullish, based on a 100% buy ratio across 7 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Future Healthcare of America comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.